These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14372767)

  • 41. Gut microflora in the pathogenesis of the complications of cirrhosis.
    Garcia-Tsao G; Wiest R
    Best Pract Res Clin Gastroenterol; 2004 Apr; 18(2):353-72. PubMed ID: 15123075
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tense ascites in cirrhotics: a new definition?
    Nagral A; Gostout CJ
    Am J Gastroenterol; 1995 Mar; 90(3):513-4. PubMed ID: 7872304
    [No Abstract]   [Full Text] [Related]  

  • 43. [Surgical approach to posthepatitic cirrhotic patient today].
    Meriggi F; Forni E
    G Chir; 1996; 17(6-7):370-8. PubMed ID: 9272983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of portal hypertension. Indications for and methods of portacaval shunt in the cirrhotic patient].
    Maillard JN; Flamant Y
    Minerva Med; 1978 Apr; 69(17):1167-70. PubMed ID: 662146
    [No Abstract]   [Full Text] [Related]  

  • 45. Hepatic hydrothorax.
    Siddappa PK; Kar P
    Trop Gastroenterol; 2009; 30(3):135-41. PubMed ID: 20306741
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Portal hypertension in chronic liver diseases and its therapy].
    Weinreich J
    Med Monatsschr; 1969 Feb; 23(2):56-60. PubMed ID: 5801507
    [No Abstract]   [Full Text] [Related]  

  • 47. [Pathogenesis of ascites in liver cirrhosis from the laparoscopy viewpoint].
    Kröhl R; Leuschner U
    Z Gastroenterol; 1972 Sep; 10(8):429-32. PubMed ID: 4266451
    [No Abstract]   [Full Text] [Related]  

  • 48. [The effect of molsidomine on portal and cardiac hemodynamics in liver cirrhosis].
    Hüppe D; Jäger D; Tromm A; Tunn S; Barmeyer J; May B
    Dtsch Med Wochenschr; 1991 May; 116(22):841-5. PubMed ID: 2036943
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pathogenesis of ascites formation in liver cirrhosis (author's transl)].
    Arbeiter G; Meyer-Burg J
    Leber Magen Darm; 1974 Oct; 4(6):299-307. PubMed ID: 4373632
    [No Abstract]   [Full Text] [Related]  

  • 50. [Is the portal system thrombosis of the cirrhotic patient latent?].
    Etienne JP; Ruyssen G; Le Parco JC
    Sem Hop; 1969 May; 45(23):1607-13. PubMed ID: 4308647
    [No Abstract]   [Full Text] [Related]  

  • 51. Evaluation of rectal mucosal hemodynamics in patients with liver cirrhosis using reflectance spectrophotometry.
    Tezuka T; Akita Y; Yoshikawa N; Mitamura K
    Am J Gastroenterol; 1997 Jun; 92(6):1022-5. PubMed ID: 9177523
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Some concepts on ammonia, porta-systemic shunts, and encephalopathy.
    Gips CH; Hindfelt B; Holmin T; Kardel T
    Scand J Gastroenterol; 1973; 8(5):385-8. PubMed ID: 4584758
    [No Abstract]   [Full Text] [Related]  

  • 53. The pathogenesis of ascites and a consideration of its treatment.
    MADDEN JL; LORE JM; GEROLD FP; RAVID JM
    Surg Gynecol Obstet; 1954 Oct; 99(4):385-91. PubMed ID: 13205408
    [No Abstract]   [Full Text] [Related]  

  • 54. [The role of portal hypertension and colloid-osmotic blood pressure in the pathogenesis of ascitis in patients with hepatic cyrrhosis].
    Kotiv BN; Basov SP
    Klin Med (Mosk); 2006; 84(3):46-9. PubMed ID: 16758923
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Recent studies of porto-arterial (parenchymo-connective tissue) circulatory disorder in Morgagni-Laennec cirrhosis and its importance in histopathogenesis of the disease process and in vascular surgical treatment].
    Paterni L
    Minerva Med; 1970 Nov; 61(91):5169-79. PubMed ID: 5489950
    [No Abstract]   [Full Text] [Related]  

  • 56. [Anatomoclinical aspects of portal thrombosis].
    Popovici Z
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1978; 27(2):127-34. PubMed ID: 580649
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Complex treatment of complications of liver cirrhosis].
    Borisov AE; Levin LA; Borisova NA; Verkhovskiĭ VS; Mosiagin VB; Faĭnzi'lberg SI
    Vestn Khir Im I I Grek; 1989 Jun; 142(6):21-5. PubMed ID: 2815466
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical significance of echography in the diagnosis of portal circulatory disorders].
    Litviakov AM; Kozlovskiĭ IV
    Ter Arkh; 1986; 58(2):93-6. PubMed ID: 3518124
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Experience with the transjugular intrahepatic portocaval shunt].
    Dagenais M; Pomier Layrargues G; Dufresne MP; Roy A; Fenyves D; Lapointe R
    Ann Chir; 1994; 48(8):671-8. PubMed ID: 7872613
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rectal 13N-ammonia test (13N-liver/heart ratio), hepatic sinusoidal pressure and prevailing portal flow direction in cirrhosis of the liver.
    Hazenberg HJ; Gips CH; Beekhuis H; Kruizinga K
    Acta Hepatogastroenterol (Stuttg); 1976; 23(5):319-27. PubMed ID: 983660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.